Matthew J. Wakefield

机构：The University of Melbourne, Walter and Eliza Hall Institute of Medical Research · ORCID：0000-0001-6624-4698

发表论文 244 篇 · 总被引 15234 次 · h-index 40

代表论文

Olaparib, durvalumab, and cyclophosphamide, and a prognostic blood signature in platinum-sensitive ovarian cancer: the randomized phase 2 SOLACE2 trial (2025 · Nature Communications · 被引 4)
RAD54L coordinates the nucleolar DNA damage response to maintain rDNA stability (2026 · The EMBO Journal)
Olaparib in HR-deficient, metastatic triple-negative breast and platinum-sensitive relapsed ovarian cancers without germline mutations in BRCA1/2: phase 2 EMBRACE trial (2026 · British Journal of Cancer)
Supplementary Table 5 from The Germline and Somatic Origins of Prostate Cancer Heterogeneity (2026)
Supplementary Table 8 from The Germline and Somatic Origins of Prostate Cancer Heterogeneity (2026)
Supplementary Table 2 from The Germline and Somatic Origins of Prostate Cancer Heterogeneity (2026)